See also this year's filing and all EDGAR filings for this company.
PDF Report 0001126234_2021_Lumos_Pharma_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 230000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
Graph
Absolute values for 0001126234, Lumos Pharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 128,449,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 335,000 |
| 3 | remainder_Assets | 249,000 |
| 4 | LiabilitiesCurrent | 6,461,000 |
| 5 | LiabilitiesNoncurrent | 6,000,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 17,265,000 |
| 9 | ResearchAndDevelopmentExpense | 9,206,000 |
| 10 | remainder_Expenses | -13,973,000 |
| 11 | remainder_Revenues | 168,000 |
| 12 | remainder_NetIncome | 6,667,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 129,033,000 |
| 1 | Liabilities | 12,461,000 |
| 2 | Expenses | 12,498,000 |
| 3 | Revenues | 168,000 |
| 4 | StockholdersEquity | 116,572,000 |
| 5 | NetIncome | -5,663,000 |
| 6 | ComprehensiveNetIncome | -5,663,000 |
| 7 | BaseVar | 80,413,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.51 |
| 9 | EconomicCapitalRatio | 4.04 |
Edgar->Model Mapping
Feature Distribution
Change over Time
